3 November 2006
BDA advises AXA Private Equity on acquisition of German specialty chemical company
Acquired CABB chemicals business in Europe, Americas and Asia
Business Development Asia LLC (“BDA”) is pleased to announce that AXA Private Equity has acquired more than 70% of the shares in CABB GmbH, a German specialty chemicals company. The remaining shares will be held by the company’s management.
CABB, formerly part of Clariant, is headquartered in Sulzbach/Taunus, Germany and produces monochloroacetic acid (MCAA) and a range of specialty intermediates with application in the PVC, pharmaceutical, agrochemical and personal care industries. With expected 2006 revenues of €140m, CABB is a global leader in the production of MCAA and has a strong presence in Europe, North America and South America, and with the support of AXA Private Equity, CABB will explore partnership opportunities with Asian producers.
BDA and Close Brothers plc acted as financial advisors to AXA, from identification of the opportunity through to its execution. Terms of the transaction were not disclosed.
The BDA transaction team was led by Andrew Huntley, Managing Director +44 20 7655 3500.
About AXA Private Equity
AXA Private Equity, an AXA Investment Managers company, with offices in Paris, Frankfurt, London, New York and Singapore, is a world leader in private equity players covering the whole range of activities (LBO, expansion, venture, co-investment, mezzanine, primary, early secondary and secondary funds of funds) with an exceptional expertise. AXA Private Equity manages and/or advises private equity funds with assets in excess of €10bn for some of the world’s leading investors. With a constant focus on transparency, performance and sustainable profitability, AXA Private Equity is supported by the expertise of its staff and its international experience.
Business Development Asia LLC was founded in 1996. BDA assists multinational corporate and financial sector clients to identify and execute acquisitions, divestments, JVs, restructuring and capital raising, in Asia and internationally. The company is headquartered in New York with offices in London, Bahrain, Mumbai, Hong Kong, Shanghai, Seoul, and Tokyo. BDA employs 50 full-time professional staff across its eight offices, supplemented by a team of senior advisors around the world. BDA’s client list includes Air Products, Cadbury Schweppes, Celestica, Dow Chemical, DuPont, Ecolab, Great Lakes, Hercules, Huntsman, Inabata, Kimberly-Clark, Lear, Lubrizol, Mars, Morgan Stanley, Nalco, Parker Hannifin, Reuters, Rohm & Haas, Ryder, Siemens, SigmaKalon, Sumitomo Chemical, TATA Auto Components, Tenneco, Tredegar, Visteon, WR Grace, and the British Government. Further information on BDA is available at www.bdapartners.com
Acquired by Solenis
Debt and equity restructuring
Acquired by Koura
Divested Amazon Papyrus Chemicals Group to The Longreach Group
Divested China phenolic resins plant to Red Avenue
Divested Epolin Chemicals to Chroma Color
Divested Asian electronic cleaning chemicals business to Nippon Kayaku
Divested Chrysal International to OAT Agrio Ltd
Divested plant health business in Japan to Nisso
Equity capital raise and new Asian partnerships
Divested Indian emulsion polymer business to Apcotex Industries
Cristal (Saudi Arabia) agreed to acquire Jiangxi Tikon TiO2 (China)
Sold stake in An Giang Plant Protection to Standard Chartered
Divested a majority stake to Navis Capital Partners
Acquired the organic pigment business of Jiangsu Multicolor
Divested Continuous Filament Mat business to Stonewood Capital
Divested Shanghai subsidiary to CPIC, China
Acquired Changzhou Pulanna Coating Co Ltd
Divested Kiian SpA, a specialty inks manufacturer, to Wise and Alcedo
Divested building materials business of Henkel Korea to Mapei of Italy